rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Shuttle Pharmaceuticals Holdings, Inc.

SHPH · Nasdaq

Health CareBiotechnologySetting upAIAI

SHPH stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 4.4% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Setting up
Weeks in an uptrend
out for 52
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$364K
Insider sales, 12 months
$1.0M
Officials’ trades on record
0
Institutions holding
4 (-3)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$965K$0$177KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months6
Sale orders, 12 months5
Buyers · sellers1 · 1
WhoDidSharesTraded
Hrt Financial Lp10% ownersold82,116at $4.4814 Jul 2026filed 15 Jul 2026
Hrt Financial Lp10% ownersold1,033at $4.6713 Jul 2026filed 15 Jul 2026
Hrt Financial Lp10% ownerbought731at $3.1110 Jul 2026filed 13 Jul 2026
Hrt Financial Lp10% ownerbought8,266at $3.389 Jul 2026filed 13 Jul 2026
Hrt Financial Lp10% ownersold18,531at $3.528 Jul 2026filed 9 Jul 2026
Hrt Financial Lp10% ownersold10,580at $3.337 Jul 2026filed 9 Jul 2026
Hrt Financial Lp10% ownersold9,022at $3.516 Jul 2026filed 7 Jul 2026
Hrt Financial Lp10% ownerbought7,851at $3.542 Jul 2026filed 7 Jul 2026
Hrt Financial Lp10% ownerbought3,959at $3.301 Jul 2026filed 2 Jul 2026
Hrt Financial Lp10% ownerbought6,755at $3.2330 Jun 2026filed 1 Jul 2026
Hrt Financial Lp10% ownerbought25,836at $3.4429 Jun 2026filed 1 Jul 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders4-3 on the quarter
New · exited2 · 5
Reported value$83K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
CITADEL ADVISORS LLCnew · filed 14 Aug 202624,354$79K+24,354
BARCLAYS PLCnew · filed 14 Aug 2026750$2,438+750
Tower Research Capital LLC (TRC)reduced · filed 11 Aug 2026389$1,264-4,252−91.6%
KELLEHER FINANCIAL ADVISORSreduced · filed 6 Aug 2026120$390-480−80.0%
30 Sep 2024 – 30 Jun 2026
369Sep 24Mar 25Sep 25Dec 25Jun 26

News

No headline names it lately.

Everyone who traded it

HRT FINANCIAL LP Company insider10% owner · last 14 Jul 20266 · 5
George Scorsis Company insiderDirector · last 8 Aug 20250 · 0
Joseph Tung Company insiderDirector · last 8 Aug 20250 · 0
Oleh Nabyt Company insiderDirector · last 8 Aug 20250 · 0
Steven M. Richards Company insiderDirector · last 8 Aug 20250 · 1
Timothy J. Lorber Company insiderChief Financial Officer · last 8 Aug 20250 · 0
Joshua Schafer Company insiderDirector · last 31 Dec 20240 · 0
Milton Brown Company insiderDirector · last 23 Dec 20240 · 2
Mira Jung Company insiderChief Scientific Officer · last 1 May 20240 · 1
Hoek Michael Vander Company insiderChief Financial Officer · last 8 Mar 20240 · 1
Bette Jacobs Company insiderDirector · last 13 Dec 20230 · 2
Anatoly Dritschilo Company insiderCEO and Chairman · last 14 Aug 20230 · 1

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Share count trendFY 2025 · to 24 Mar 2026176%
Cash and equivalentsFY 2025 · to 31 Dec 2025$334K

Analyst forecasts

No analyst forecasts yet.